JUNE 19, Creating The First Global Pharmacy-Led Health & Wellbeing Enterprise
|
|
- Ginger Simpson
- 5 years ago
- Views:
Transcription
1 JUNE 19, 2012 Creating The First Global Pharmacy-Led Health & Wellbeing Enterprise
2 JUNE 19, 2012 Creating The First Global Pharmacy-Led Health & Wellbeing Enterprise
3 FORWARD-LOOKING STATEMENT SAFE HARBOR Statements in these materials and the accompanying presentation that are not historical are forward-looking statements made based on current market, business and regulatory expectations and involve risks, uncertainties and assumptions that could cause actual results to vary materially. Except to the extent required by the law, we undertake no obligation to update publicly any forward-looking statement after this presentation, whether as a result of new information, future events, changes in assumptions or otherwise. Please see the Cautionary Note regarding Forwarding-Looking Statements on the attached Appendix and our latest Form 10-K and 10-Q for a discussion of risk factors as they relate to forward-looking statements. Today s presentation includes certain non-gaap financial measures. Please refer to the Appendix for reconciliations to the most comparable GAAP measure and related information. The Appendix also includes certain definitions and assumptions used in today s presentation. 3
4 GREG WASSON WALGREENS PRESIDENT & CHIEF EXECUTIVE OFFICER
5 UNMATCHED GLOBAL PLATFORM NOW AND INTO THE FUTURE World Leader in Pharmacy-Led Health & Wellbeing Largest Global Pharmaceutical Wholesale and Distribution Network Broad Portfolio of Trusted Iconic Brands 5
6 AGENDA Vision, Strategy & Structure Alliance Boots Greg Wasson, Walgreens President and CEO Stefano Pessina, Alliance Boots Executive Chairman George Fairweather, Alliance Boots Group Finance Director Shareholder Value Creation & Financial Highlights Wade Miquelon, Walgreens Executive Vice President and CFO 6
7 COMPELLING STRATEGIC RATIONALE 1 2 COMPLEMENTARY CAPABILITIES & ASSETS 3 4 REVENUE & PROFIT POOL DIVERSIFICATION SUBSTANTIAL SYNERGY POTENTIAL Procurement Prescription drugs Branded goods Private brands Indirect spend Revenue Enhancing Beauty Own brands Wellness solutions Best & Next Practices Store formats Loyalty E-commerce Prevention & adherence Pharmacy PLATFORM FOR FUTURE GROWTH Walgreens Today Combined Vision US Pharmacy: Health & Daily Living Global Pharmacy: Health & Wellbeing Global Wholesale & Distribution 7
8 COMPLEMENTS AND ACCELERATES WALGREENS CORE STRATEGIES Continuous Improvement & Innovation Health & Daily Living Destination Expand New Markets & Channels Advance the Role of Community Pharmacy Employee Engagement to Enhance the Customer Experience 8
9 PLANNED TRANSACTION STRUCTURE Step Step 1 Walgreens to purchase 45% of Alliance Boots equity Option to purchase remaining 55% of Alliance Boots equity 2 Exercise option to acquire remaining 55% of Alliance Boots equity Exercisable during six month period beginning 2.5 years after Step One close Walgreens assumes Alliance Boots thenoutstanding net debt Step 1 Step 2 Total Cash $4.0 B **$4.9 B $8.9 B Walgreens Shares Issued Transaction Summary ~83.4 M ~144.3 M ~227.7M **Assumes a FX rate of $1.55 per Pounds Sterling. To be paid in 3.1 B Pounds Sterling Subject to adjustment if Walgreens share price below $31.18 at time of exercise Two-Step Transaction: Optimal balance of strong financial returns while mitigating risk Enables significant synergies and value creation potential Ensures Alliance Boots and Walgreens continued solid execution on current business Enables thoughtful planning of combined future global enterprise Subject to change in certain circumstances. Forward-Looking Statements See cautionary note in attached Appendix 9
10 A FOUNDATION OF WORLD CLASS TALENT AND ASSETS.com.com 10
11 STEFANO PESSINA ALLIANCE BOOTS EXECUTIVE CHAIRMAN
12 ALLIANCE BOOTS: OVER A CENTURY OF ACHIEVEMENT Product of many years of organic growth and building value through mergers, acquisitions, partnerships and alliances, inside and outside the business at the forefront of industry progression Consistently strong growth 88% growth in trading profit * in the last five years; highly cash generative businesses Focus on high standards of customer care and service for all stakeholders, including: consumers and patients, independent pharmacies, pharmaceutical manufacturers, suppliers, governments and our own people 1849: First Boots store opened 1938: UniChem founded (UK) 1991: Creation of Alliance Santé: merger of Alleanza Salute Italia, ERPI and IFP 2006: Creation of Alliance Boots: merger of Alliance UniChem with Boots 2008: Joint venture in China with GP Corp 2010: Acquisitions of Hedef Alliance and ANZAG 1851: Creation of Maison Thomas (wholesale, France) 1977: Alleanza Farmaceutica founded 1998: Creation of Alliance UniChem: merger of Alliance Santé with UniChem 2007: Alliance Boots acquired by AB Acquisitions 2009: Merger of Boots Opticians with D&A * Including share of trading profit of associates and joint ventures. See definition in appendix for trading profit. 12
13 WALGREENS AND ALLIANCE BOOTS: A NATURAL FIT Strong heritage dating back over 100 years Complementary geographic footprints Creates significant and sustainable industrial value Commitment to further growth and development 13
14 THE FIRST GLOBAL PHARMACY-LED HEALTH AND WELLBEING LEADER Each business will continue to excel at what it does best - grow core businesses in existing markets, focus on service, innovation and value creation Companies will draw support from each other to accelerate growth - synergies, expertise, shared sales channels Together we will lead the global effort to make quality healthcare more affordable and accessible to the communities we serve The combined business creates new opportunities - attract new partners in new markets, new opportunities in existing markets, fundamentally new model changes relationship with industry 14
15 LEADING THE INDUSTRY INTO THE FUTURE Together, Walgreens & Alliance Boots will be: At the forefront of the current structural changes in global healthcare The health & wellbeing partner of choice for customers, suppliers, employees and pharmacists Focused on investing for the future from a platform of sustainable global strength Leading the evolution of global healthcare Capturing growth across all markets Changing the industry shaping it for the future Delivering benefits for everyone patients, partners, payers, people 15
16 GEORGE FAIRWEATHER ALLIANCE BOOTS GROUP FINANCE DIRECTOR
17 LEADING INTERNATIONAL PHARMACY-LED HEALTH & BEAUTY GROUP WORLD CLASS CAPABILITIES AND A PRESENCE IN MORE THAN 25 * COUNTRIES PHARMACY-LED, HEALTH & BEAUTY RETAILING 3,330 * + health & beauty retail stores, ~3,200 * of which have a pharmacy 260 * + million prescriptions dispensed annually PHARMACEUTICAL WHOLESALING & DISTRIBUTION Operating 370 * + pharmaceutical wholesale distribution centers Delivering 4.5 * + billion units per annum to more than 170,000 * pharmacies, doctors, health centers and hospitals PRODUCT BRANDS Highly regarded and innovative product brands including No7, Soltan, Botanics and Boots Laboratories Continued internationalisation via sales to independent pharmacies, retail partners, distributors and online * Figures are approximations as of March 31, 2012 and include associates and joint ventures 17
18 ALLIANCE BOOTS: A STRONG TRACK RECORD OF PROFITABLE GROWTH A strong track record of organic and M&A growth, driven by a consistent focus on customer service, innovation and international expansion Strong performance since group creation six years ago and subsequent privatization Consistent double-digit profit growth and strong cash generation Trading profit * growth Cash generated from operations % in the last 5 years 1, ,176 1,300 Exceeded 1 billion in each of the last 5 years 1,601 1,309 1,152 1,130 1,045 06/07** 07/08** 08/09 09/10 10/11 11/12 ( million) *Including share of trading profit of associates and joint ventures (including Galenica) See definition in appendix for trading profit **Pro Forma Figures for the year ended March 31, /08** 08/09 09/10 10/11 11/12 ( million) **Pro Forma 18
19 ALLIANCE BOOTS: BALANCED REVENUE AND PROFIT GENERATION ALLIANCE BOOTS REVENUE * ALLIANCE BOOTS TRADING PROFIT * Share of associates and joint ventures 9% 25.4 B 1.3 B Health & Beauty 28% Share of associates and joint ventures 8% Health & Beauty 61% Pharmaceutical Wholesale 63% Pharmaceutical Wholesale 31% Does not include Contract Manufacturing revenue and Intra-Group revenue Does not include Contract Manufacturing and Corporate Costs * Figures for the year ended March 31, 2012, including Galenica 19
20 HEALTH & BEAUTY DIVISION European market leader in pharmacy with stores in the UK, Norway, the Republic of Ireland, The Netherlands and Lithuania Boots Opticians - ~625 practices in the UK, including franchises UK market leader in pharmacy and health and beauty categories Growing presence in Asia (Thailand) and via franchising (Gulf) Further internationalization opportunities via own product brands Health & Beauty UK 11/12 Revenue 6,706 million Health & Beauty International 11/12 Revenue 965 million Lifestyle 15% Optical 5% Dispensing & Related Income 35% The Netherlands 17% Thailand 9% Other 7% Norway 43% Beauty & Toiletries 32% Retail Health 13% Republic of Ireland 24% Figures for the year ended March 31,
21 PHARMACEUTICAL WHOLESALE DIVISION Number one pharmaceutical wholesaler in Europe Provides high core service levels to pharmacies in terms of frequency of delivery, product availability, delivery accuracy and reliability Offers innovative added value services to support independent pharmacists and develop their businesses including membership of the Alphega Pharmacy network across Europe Provides pharmaceutical manufacturers with a range of services, including prewholesale and contract logistics, specialized medicines delivery and home healthcare Increasing presence in emerging markets including Turkey, Egypt and through a joint venture in China 8,393 Pharmaceutical Wholesale Revenue 13,154 10,626 9,746 16,828 Spain 7% Other ** 16% Revenue * by country 11/12 revenue 16,828 million France 27% 07/08* 08/09 09/10 10/11 11/12 *Pro Forma ( million) Turkey 10% UK 18% Germany 22% *Figures for the year ended March 31, 2012 **Others include: Egypt, Czech Republic, Norway, Romania, Lithuania, The Netherlands 21
22 LEADING PRODUCT BRANDS UK's leading skincare brand Launched in 1935 Internationally acclaimed anti ageing beauty serums Renowned range of cosmetics Sold in Target stores and online and Ulta throughout the US and on websites Contains plant extracts Launched in 1995 Developed with Royal Botanic Gardens at Kew Widest range of healthcare products in the UK Launched in 2010 Innovative product development Developed for independent pharmacists Launched in France in 2008 Sold in five countries, including Spain, Italy and Germany in collaboration with Procter & Gamble One of the leading suncare brands in the UK Launched in 1939 Exclusive range of generic medicines Sold in five countries across Europe 22
23 WADE MIQUELON WALGREENS EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
24 TRANSACTION TERMS TERMS STEP ONE STEP TWO (Option Exercise) STRUCTURE CONSIDERATION FINANCING Purchase 45% of Alliance Boots equity, excluding the benefit of minority ownership interest in Galenica Receive call option to acquire remaining 55% of Alliance Boots ~60% cash, ~40% Walgreens equity Cash fixed at $4.0 B Shares fixed at 83.4M ~$3.5 B of short & intermediate-term debt ~$0.5 B cash 55% buyout investment, excluding the benefit of minority ownership interest in Galenica 3.1 B Pounds Sterling Shares fixed at M Walgreens assumes outstanding Alliance Boots net debt Consideration and mix subject to adjustment in certain circumstances Cash portion to be debt financed subject to cash available and delivered in Pounds Sterling TIMING Expected to close by September 1, 2012 Option exercisable during the 6 month period beginning 2.5 years after Step One closing CONDITIONS Subject to regulatory approvals Subject to Walgreens shareholder approval Subject to regulatory approvals Investment in Alliance Boots will be reduced from 45% to 42% for nominal consideration if the option is not exercised in certain circumstances GOVERNANCE Stefano Pessina and a KKR Alliance Boots director will join the Walgreens Board 4 Walgreens members to join Alliance Boots Board Walgreens has negative protective rights Walgreens and Alliance Boots will be combined in accordance with shared vision 24
25 GAME-CHANGING SCALE AND CAPABILITIES Pharmacy-led Health & Wellbeing Industry COMBINED Prescription Drug Purchasing Largest global purchaser of prescription drugs Daily Living Purchasing Combined presence of over 11,000* iconic and trusted retail stores in 12 countries Indirect Spend ~$7 billion of combined indirect spend or goods not for resale (GNFRS) Beauty Offerings Best retail portfolio of own product beauty brands to be expanded in US and beyond. Strong retail footprint and significant UK based R&D capabilities. Private Brand Combined portfolio of brands and products offers significant expansion opportunity and purchasing volume. *Including associates and joint ventures 25
26 GAME-CHANGING SCALE AND CAPABILITIES Pharmacy-led Health & Wellbeing Industry COMBINED Innovative Store Format Innovative and customized health & beauty centric locations Expansion of Well Experience, flagship, and other profitable and relevant formats Loyalty Alliance Boots has world class loyalty program that can be leveraged globally Walgreens plans a full rollout loyalty program September 2012 Healthcare Services Prevention & Adherence Expansion potential for Alliance Boots services including weight management, eye clinics, and smoking prevention Continued expansion of retail, work-site, and hospital formats. Expansion and program development of vaccinations, screenings, diagnostic and other preventative services E-Commerce Global e-commerce capabilities uniquely linking clicks with bricks to become the multi-channel leader in health and wellbeing. 26
27 CREATING VALUE THROUGH SYNERGIES BASELINE SYNERGIES REPRESENT ONLY 1% OF COMBINED PHARMACY AND GENERAL MERCHANDISE COST OF GOODS SOLD BY 2016* Combined synergies expected to reach $1 B in year 4 * SYNERGY OPPORTUNITIES Procurement Prescription drugs Branded goods Private brands Indirect spend Revenue Enhancing Beauty Wellness Solutions Own Brands Best Practice Sharing Store format Loyalty E-commerce Prevention & Adherence Pharmacy $ in Billions Expected combined synergies of $100 M - $150 M in year 1 * Call Option Window Year 1 Year 2 Year 3 Year 4 * Forward-Looking Statements See cautionary note in attached Appendix. 27
28 WALGREENS YEAR ONE FINANCIAL IMPACTS *Expected FY 2013 Accretion of $.23 - $.27 per diluted share Expected Accretion Details 1. FY 2013 EPS accretion estimate assumes no further share repurchases (858.5 M basic shares outstanding at May 31, 2012) 2. Pro-forma net income adjusted for interest from $3.5 B investment financing, Walgreens share of synergies, and equity method income from 45% investment in Alliance Boots 3. Gives effect to the issuance of 83.4M shares to Alliance Boots shareholders in step one Assumptions Combined synergies of $100 M - $150 M in year one Excludes one-time transaction-related costs Assumes August 31, 2012 close Figures assume constant currency *45% periodic Alliance Boots income available to equity holders is subject to GAAP adjustments, foreign exchange translations, and basis difference amortization * Forward-Looking Statements See cautionary note in attached Appendix. 28
29 COMBINED ORGANIZATION LONG-TERM FINANCIAL GOALS FY 2016 Goals* Revenue LIFO EBIT LIFO Provision & Transaction Amortization Synergies Operating Cash Flow Net Debt (excludes lease obligations) Projected Shares Outstanding >$130 Billion $8.5-9 Billion ~$0.5 Billion $1 Billion ~$7 Billion ~$11 Billion** ~1.1 Billion shares*** Target Dividend Payout Ratio 30-35% Estimated Pro forma IRR >20% *All figures assume constant currency and exercise of option **Net debt defined as balance sheet debt less cash ***Projected shares outstanding assumes no share repurchase Forward-Looking Statements See cautionary note in attached Appendix. 29
30 MEANINGFUL REVENUE GROWTH AND DIVERSIFICATION BENEFITS Revenue diversified across geographies Revenue diversified across multiple businesses Revenue growth platform for new and expanded markets, channels and products Walgreens Trailing Four Quarters * FY 2016 Organic Goal ** US Pharmacy US Daily Living (Front End) Global Wholesale International Pharmacy & Daily Living (Front End) Total Revenue ~$73 Billion Total Revenue *Figures ending May 31, 2012 >$130 Billion ** US Daily Living (Front End) US Pharmacy ** Forward-Looking Statements See cautionary note in attached Appendix. 30
31 MEANINGFUL PROFIT DIVERSIFICATION AND GROWTH BENEFITS Profit diversified across geographies including, US, Europe and key emerging markets Profit diversified across multiple businesses Profitable expansion opportunities in domestic front end, wholesaling, and international pharmacy, health & beauty Walgreens Trailing Four Quarters* FY 2016 Organic Goal US Pharmacy Adjusted LIFO EBIT ~$3.7 B (LIFO EBIT ~4.1 B) US Daily Living (Front End) *Figures ending May 31, 2012 **Adjusted LIFO EBIT excludes sale of WHI of $434 M International Pharmacy & Front End Global Wholesale LIFO EBIT $8.5-9 Billion US Daily Living (Front End) US Pharmacy Forward-Looking Statements See cautionary note in attached Appendix. 31
32 WALGREENS CAPITAL ALLOCATION POLICY Return Cash to Shareholders Reinvest in Core Strategies Maintain Strong Balance Sheet and Financial Flexibility Invest in Strategic Opportunities 32
33 WALGREENS AND ALLIANCE BOOTS: CREATING THE FUTURE TOGETHER Creating the First Global Pharmacy-led Health and Wellbeing Enterprise Thoughtful Execution 33
34 Q&A Creating the First Global Pharmacy-led Health and Wellbeing Enterprise Thoughtful Execution 34
35 APPENDIX
36 CERTAIN DEFINITIONS & ASSUMPTIONS CERTAIN ASSUMPTIONS: Unless the context otherwise indicates or requires: This presentation assumes constant currency exchange rates after the date hereof based on current rates; References to the combined company assume that Walgreens has elected to exercise its option in Step 2 during the period it has the right to do so; Financial data regarding Alliance Boots has been derived from financial statements prepared in accordance with IFRS (not US GAAP); and Galenica reported ~3.2 B CHF (~2.2 B Pounds Sterling) for Sales & ~255.6 M CHF (~175.5 M Pounds Sterling) for net profit. Assuming exchange rate of Pounds Sterling per CHF. Alliance Boots 25.5% associate interest in Galenica is reflected in its financial statements but is not part of this transaction. Financial goals assume no major mergers and acquisitions and other strategic transactions Trading Profit - Profit from operations before amortization of customer relationships and brands, exceptional items and share of posttax earnings of associates and joint ventures Alliance Boots Pro Forma Information - Alliance Boots plc was acquired on 26 June To assist in understanding the performance of the Group, pro forma financial information is set out above to show the results from continuing operations of the Group for the year ended 31 March 2008 as if the acquisition of Alliance Boots plc in June 2007 had taken place prior to 31 March Alliance Boots plc was created on 31 July 2006 through the merger of Alliance UniChem Plc and Boots Group PLC. The percentage increase in trading profits over the last five years is calculated using pro forma financial information for 2006/07 as if the two former groups had always been combined. All descriptions of the agreement and the transactions contemplated thereby are qualified in their entirety by reference to the full text of the agreements, copies of which will be filed with the SEC on a Form 8-K 36
37 YEAR ONE EXPECTED FINANCIAL STATEMENT IMPACT EQUITY METHOD ACCOUNTING INCOME STATEMENT Walgreens Equity Investment Accretion Year 1 Impact* Cash Impact Explanation ~45% of Alliance Boots income available to equity holders No immediate impact to Walgreens Cash remains in Alliance Boots business Walgreens will increase its net income by its 45% proportionate share of Alliance Boots periodic income available to equity holders, excluding Galenica and subject to GAAP adjustments, foreign exchange translations, and basis difference amortization. Walgreens Core Accretion Walgreens share of $100 - $150 M combined synergies Available to Walgreens Synergies expected to improve Walgreens core business Interest Expense Calculated from $3.5 Billion principal debt financing Cash outflow Interest expense increases due to ~$3.5 Billion principal debt financing Tax Impact Tax rate expected to decrease Cash outflow as tax expense is increased due to increase in net income attributable to synergies Alliance Boots tax rate is lower than Walgreens U.S. tax rate effectively lowering Walgreens expected effective tax rate Total EPS $.23 - $.27 EPS accretion Positive year one cash flows Include core synergies and equity investment accretion *Excludes one time costs associated with transaction Forward-Looking Statements See cautionary note in attached Appendix 37
38 YEAR ONE EXPECTED FINANCIAL STATEMENT IMPACT EQUITY METHOD ACCOUNTING BALANCE SHEET Year 1 Impact* Explanation Assets Liabilities Equity ~$6.6 Billion in assets (500 M financed with cash) +~45% of Alliance Boots periodic income available to equity holders, excluding Galenica and subject to GAAP adjustments, foreign exchange translations, and basis difference amortization ~$3.5 Billion short-term and intermediate-term debt ~$2.7 Billion in equity from Walgreens share issuance +~45% of Alliance Boots periodic income available to equity holders, excluding Galenica, and subject to GAAP adjustments, foreign exchange translations, and basis difference amortization Total purchase price of the 45% minority stake is placed on the balance sheet as a non-current asset Non-current assets are increased by the fair value of the call option which includes the fair value of the 3% Walgreens equity recoupment possibility As income is generated, Alliance Boots will increase the value of the asset by its 45% proportionate share of Alliance Boots periodic income available to equity holders, excluding Galenica and subject to GAAP adjustments, foreign exchange translations, and basis difference amortization Used to partially finance step one of the transaction Periodic income to be included in Walgreens net income, excluding Galenica *Excludes one time costs associated with transaction Forward-Looking Statements See cautionary note in attached Appendix 38
39 YEAR ONE EXPECTED FINANCIAL STATEMENT IMPACT EQUITY METHOD ACCOUNTING CASH FLOW STATEMENT Year One Impact* Explanation Operating Investing Financing Cash and Cash Equivalents Inflow: Walgreens share of $100 - $150 M combined synergies Outflow: ~$4.0 B to purchase Increase from Walgreens core accretion due to expected purchasing synergies EPS accretion from equity investment is backed out of the operating cash flows Increased tax expense from additional income and increased after tax interest Initial investment to purchase 45% of Alliance Boots equity Inflow ~$3.5 Billion Short term-debt & intermediate-term debt Outflow ~$0.5 Billion Existing cash used to partially fund investment *Excludes one time costs associated with transaction Forward-Looking Statements See cautionary note in attached Appendix 39
40 NON-GAAP FINANCIAL MEASURES The following information provides reconciliations of the non-gaap financial measures, as defined under SEC rules, presented herein to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles in the United States (GAAP). Walgreens has provided these non-gaap financial measures, which are not calculated or presented in accordance with GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with GAAP. These non- GAAP financial measures are provided because management believes that the non-gaap financial measures presented provide for greater transparency of supplemental information considered by management in its financial and operational decision-making. These non-gaap financial measures may be different from non-gaap financial measures used by other companies. These non-gaap financial measures should not be considered superior to or as a substitute for, and should be considered in conjunction with, the GAAP financial measures presented herein. 40
41 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION Statements in these materials and the accompanying presentation that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of Words such as expect, likely, outlook, forecast, would, could, should, can, will, project, goal, intend, plan, continue, sustain, synergy, on track, believe, seek, estimate, anticipate, may, possible, assume, variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that could cause actual results to vary materially from those indicated, including: the ability to satisfy the closing conditions and consummate the proposed transactions on a timely basis or at all, the occurrence of any event, change or other circumstances that could give rise to the termination of the Purchase and Option Agreement or the financing commitment letter, Walgreens ability to consummate on a timely basis or at all the financing arrangements contemplated by the financing commitment letter, Walgreens ability to subsequently arrange for and consummate on a timely basis or at all permanent financing on acceptable terms, risks that the proposed transactions disrupt plans and operations of either the Walgreens or Alliance Boots, the ability to realize anticipated synergies, the ability to achieve anticipated financial results, the amount of costs, fees, expenses and charges incurred by Walgreens or Alliance Boots related to the transaction, the risks associated with international business operations, the risks associated with Walgreens lack of majority control over the Alliance Boots business, whether the option to acquire the remainder of the Alliance Boots equity interest will be exercised, changes in vendor, payer and customer relationships and terms, changes in network participation, and other factors described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, each of which is incorporated herein by reference, and in other documents that we file or furnish with the Securities and Exchange Commission. The financial and operating goals and expected return described in these materials and the accompanying presentation are forward-looking statements based on numerous assumptions made by management, including assumptions concerning revenue, operating expenses, overhead, synergies, interest rates, industry performance, general business and economic conditions, competition, access to markets and distribution channels, availability and pricing of goods, foreign currency rates and other matters, all of which are inherently subject to significant uncertainties and contingencies and many of which are beyond Walgreens control. It is expected that there will be differences between actual results and these goals and expectations, and actual results may be materially greater or less than those forward-looking statements. Accordingly, there can be no assurance that the assumptions made in preparing those goals and expectations will prove accurate or that any of such forward-looking statements will be realized. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by any such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Except to the extent required by law, Walgreens does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement after the date of this report, whether as a result of new information, future events, changes in assumptions or otherwise. 41
Walgreens-Alliance Boots Investor Call
Walgreens-Alliance Boots Investor Call August 6, 2014 Investor Call Agenda Introduction & Safe Harbor Alliance Boots Step 2 Update Global Management Structure Corporate Structure Rick Hans, CFA Divisional
More informationWalgreens Boots Alliance Reports Fiscal 2015 Year-End and Fourth Quarter Results
October 28, 2015 Walgreens Boots Alliance Reports Fiscal 2015 Year-End and Fourth Quarter Results Adjusted fiscal year 2015 net earnings attributable to Walgreens Boots Alliance per diluted share increase
More informationWalgreens Boots Alliance Reports Fiscal 2016 Second Quarter Results
Alliance Reports Fiscal 2016 Second Quarter Results Adjusted second quarter net earnings attributable to Alliance per diluted share increase 11.0 percent to $1.31 compared with the year-ago period; GAAP
More informationWalgreens Boots Alliance Reports Fiscal 2016 Third Quarter Results
Alliance Reports Fiscal 2016 Third Quarter Results GAAP third quarter net earnings attributable to Alliance per diluted share decrease 14.4 percent to $1.01 compared with the year-ago period; Adjusted
More informationWalgreens Boots Alliance Fiscal year end 2015 and 4Q earnings conference call. 28 October 2015
Walgreens Boots Alliance Fiscal year end 2015 and 4Q earnings conference call 28 October 2015 Fiscal year end 2015 and 4Q earnings call agenda Topic Introduction & Safe Harbor Business Overview Financial
More informationWalgreens Boots Alliance Reports Fiscal 2017 First Quarter Results
Walgreens Boots Alliance Reports Fiscal 2017 First Quarter Results First quarter highlights GAAP diluted net earnings per share decrease 4.0 percent from the year-ago quarter, to $0.97; Adjusted diluted
More informationWalgreens Boots Alliance 2015 analyst meeting financial session. Safe Harbor and Non-GAAP
Walgreens Boots Alliance 2015 analyst meeting financial session 16 April 2015 Safe Harbor and Non-GAAP Certain statements and projections of future results made in this presentation constitute forward-looking
More informationWalgreens Boots Alliance Reports Fourth Quarter and Fiscal 2017 Results
October 25, 2017 Boots Alliance Reports Fourth Quarter and Fiscal 2017 Results Fourth quarter highlights GAAP diluted net earnings per share were $0.76, down 20.0 percent from the year-ago quarter due
More informationWalgreens Boots Alliance Reports Fourth Quarter and Fiscal 2016 Results
20 October 2016 Boots Alliance Reports Fourth Quarter and Fiscal 2016 Results Fourth quarter highlights GAAP diluted net earnings per share increase to $0.95 from $0.02 in the year-ago quarter; Adjusted
More informationWalgreens Boots Alliance 3Q16 Consolidated Financial Results Earnings conference call. 6 July 2016
Walgreens Boots Alliance 3Q16 Consolidated Financial Results Earnings conference call 6 July 2016 Agenda Topic Introduction & safe harbor Opening remarks Financial review Questions & answers Speaker Gerald
More informationWalgreens Boots Alliance Reports Fiscal 2019 First Quarter Results Delivers Double Digit Percentage Growth in Earnings Per Share (EPS)
Walgreens Boots Alliance Reports Fiscal 2019 First Quarter Results Delivers Double Digit Percentage Growth in Earnings Per Share (EPS) First quarter highlights, year-over-year Sales increased 9.9 percent
More informationWalgreens Boots Alliance Reports Fiscal 2018 First Quarter Results
January 4, 2018 Walgreens Boots Alliance Reports Fiscal 2018 First Quarter Results First quarter highlights GAAP diluted net earnings per share were $0.81, down 16.5 percent from the year-ago quarter mainly
More informationWalgreens Boots Alliance Reports Fiscal 2018 Third Quarter Results
Alliance Reports Fiscal 2018 Third Quarter Results June 28, 2018 Third quarter highlights GAAP diluted net earnings per share increased 26.2 percent from the year-ago quarter, to $1.35; Adjusted diluted
More informationWalgreens Boots Alliance Reports Fiscal 2018 Second Quarter Results
March 28, 2018 Alliance Reports Fiscal 2018 Second Quarter Results Second quarter highlights GAAP diluted net earnings per share were $1.36, up 38.8 percent from the year-ago quarter; Adjusted diluted
More informationFourth Quarter and Fiscal 2016 Results. 20 October 2016
Fourth Quarter and Fiscal 2016 Results 20 October 2016 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that
More informationFiscal 2017 First Quarter Results. 5 January 2017
Fiscal 2017 First Quarter Results 5 January 2017 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are not
More informationFiscal 2018 Third Quarter Results. 28 June 2018
Fiscal 2018 Third Quarter Results 28 June 2018 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are not
More informationWalgreen Co. Reports Fiscal 2014 Second Quarter Results
March 25, 2014 Walgreen Co. Reports Fiscal 2014 Second Quarter Results Company reports adjusted second quarter earnings per diluted share of 91 cents, compared with adjusted earnings per diluted share
More informationSafe harbor and non-gaap
Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are not historical including, without limitation, estimates
More informationFourth Quarter and Fiscal 2018 Results. October 11, 2018
Fourth Quarter and Fiscal 2018 Results October 11, 2018 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference January 15, 2014 Greg Wasson President and CEO 2 1 Safe Harbor and Non-GAAP Certain statements and projections of future results made in these presentations constitute
More informationWalgreen Co. Reports Fiscal 2013 First Quarter Results
December 21, 2012 Walgreen Co. Reports Fiscal 2013 First Quarter Results Company reports adjusted first quarter earnings per diluted share of 58 cents, compared with adjusted earnings per diluted share
More informationFiscal 2019 First Quarter Results. December 20, 2018
Fiscal 2019 First Quarter Results December 20, 2018 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are
More informationWalgreen Co. Reports Fiscal 2012 Third Quarter Earnings of $537 Million, or 62 Cents per Diluted Share
June 19, 2012 Walgreen Co. Reports Fiscal 2012 Third Quarter Earnings of $537 Million, or 62 Cents per Diluted Share Results include 1 cent per diluted share due to costs related to strategic transaction
More information34 th Annual J.P. Morgan Healthcare Conference. Steve Collis, President & CEO Tim Guttman, EVP & CFO
34 th Annual J.P. Morgan Healthcare Conference Steve Collis, President & CEO Tim Guttman, EVP & CFO January 12, 2016 Steve Collis President & CEO Cautionary Note Regarding Forward-Looking Statements Certain
More informationAlliance Boots Preliminary results announcement for the year ended 31 March Strong growth in revenue, EBITDA and trading profit
Press release 18 May 2009 Alliance Boots Preliminary results announcement for the year ended 31 March 2009 Strong growth in revenue, EBITDA and trading profit Alliance Boots, the international pharmacy-led
More information3 rd Quarter Fiscal 2019
3 rd Quarter Fiscal 2019 SUPPLEMENTAL INFORMATION December 19, 2018 SAFE HARBOR STATEMENT Cautionary Statement Regarding Forward Looking Statements Statements in this presentation that are not historical,
More informationMcKesson Corporation J.P. Morgan Healthcare Conference
McKesson Corporation J.P. Morgan Healthcare Conference John Hammergren Chairman and Chief Executive Officer Forward-Looking Statements Some of the information in this presentation is not historical in
More informationSafe Harbor Statement
January 3, 2018 Safe Harbor Statement Statements in this presentation that are not historical, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation
More informationUnited Rentals to Acquire RSC Holdings
United Rentals to Acquire RSC Holdings Investor Presentation DECEMBER 2011 Introductory Information Cautionary Statement Regarding Forward-Looking Statements This document contains forward-looking statements
More informationSafe Harbor Statement
June 27, 2018 Safe Harbor Statement Cautionary Statement Regarding Forward Looking Statements Statements in this presentation that are not historical, are forward-looking statements made pursuant to the
More informationSafe Harbor Statement
April 12, 2018 Safe Harbor Statement Cautionary Statement Regarding Forward Looking Statements Statements in this presentation that are not historical, are forward-looking statements made pursuant to the
More informationALLIANCE BOOTS INTERIM RESULTS SHOW MERGED GROUP IS ON TRACK
Press release 14 November 2006 ALLIANCE BOOTS INTERIM RESULTS SHOW MERGED GROUP IS ON TRACK Interim results announcement Alliance Boots plc, the international pharmacy-led health and beauty group, today
More informationHelping people look and feel their best
Helping people look and feel their best 2008/09 Annual Review for the year ended 31 March 2009 Alliance Boots Annual Review 2008/09 Contents 01 Group highlights 02 Our mission, purpose and values 04 Our
More informationMcKesson Corporation J.P. Morgan Healthcare Conference
McKesson Corporation J.P. Morgan Healthcare Conference John Hammergren Chairman and Chief Executive Officer Forward-Looking Statements Some of the information in this presentation is not historical in
More informationCIGNA CORPORATION INVESTOR PRESENTATION. May 5, Cigna
CIGNA CORPORATION INVESTOR PRESENTATION May 5, 2017 1 Forward looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
More informationWellCare to Acquire Meridian
WellCare to Acquire Meridian May 9, 018 Cautionary Statements This presentation contains "forward-looking" statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation
More informationShareholders Expected to Benefit from a Number of Outcomes
Shareholders Expected to Benefit from a Number of Outcomes Benefits for Shareholders F I N A N C I A L S U P P L E M E N T Enhanced competitive positioning Low- to mid-single digit accretion in the second
More informationCIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE
CIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE March 2018 Important Information for Investors and Shareholders FORWARD LOOKING STATEMENTS
More informationFiscal Year 2011 Core Strategies and Milestones Express Scripts Update
Walgreen Co. Reports 6.5 Percent Increase in Fourth Quarter Sales; Adjusted Earnings Per Diluted Share Increase to 57 Cents in Quarter, Excluding Gain from Sale of Walgreens Health Initiatives; and GAAP
More informationFourth Quarter 2017 Earnings Conference Call
Fourth Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer February 8, 2018 Important Information No Offer
More informationProject Mountain Investor Presentation. AECOM Investor Presentation. World Trade Center Manhattan, New York, U.S.A.
Project Mountain Investor Presentation AECOM Investor Presentation World Trade Center Manhattan, New York, U.S.A. Safe Harbor Disclosures Cautionary Note Regarding Forward-Looking Statements All statements
More informationMcKesson Corporation Fiscal 2018 Financial Performance Fiscal 2019 Annual Outlook. Financial Results and Company Highlights May 24, 2018
McKesson Corporation Fiscal 2018 Financial Performance Fiscal 2019 Annual Outlook Financial Results and Company Highlights Forward-Looking Statements Some of the information in this presentation is not
More informationInvestor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
More informationHill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016
Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private
More informationMAISONS DU MONDE: FULL-YEAR 2018 RESULTS
PRESS RELEASE MAISONS DU MONDE: FULL-YEAR 2018 RESULTS Strong performance in line with targets Continued solid momentum in online and international sales Focus on strategic pillars to deliver further profitable
More informationQuarterly Update FY16 Fourth Quarter. November 8, 2016
Quarterly Update FY16 Fourth Quarter November 8, 2016 Johnson Controls International plc Cautionary Statement Regarding Forward-Looking Statements Johnson Controls International plc has made statements
More informationCreating Value by Accelerating Transformation & Growth
Creating Value by Accelerating Transformation & Growth Univar Announces Agreement to Acquire Nexeo September 17, 2018 1 2018 Univar, Inc. All rights reserved. Forward-Looking Statements This communication
More informationSigma Pharmaceuticals Limited
Investor Relations Contact: Gary Woodford Corporate Affairs Manager Gary.Woodford@signet.com.au Phone: 03 9215 9632 Mobile: 0417 399 204 Mark Hooper CEO and Managing Director Gary Woodford Corporate Affairs
More informationCombination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014
Combination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014 David Dvorak President and Chief Executive Officer Jim Crines EVP, Finance, and Chief Financial Officer Cautionary Statement
More informationSEPTEMBER 17, 2018 SKY BETTING & GAMING UPDATE
SEPTEMBER 17, 2018 SKY BETTING & GAMING UPDATE CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements and information within the meaning of the Private
More informationCVS HEALTH/AETNA INVESTOR CALL SCRIPT
MIKE McGUIRE, CVS HEALTH IRO Good morning, everyone. Thanks so much for joining us this morning to hear about the definitive merger agreement we announced yesterday to acquire Aetna, one of the nation
More informationFINANCIAL HIGHLIGHTS. Sales
Walgreen Co. Reports 11.4 Percent Increase in Diluted Earnings Per Share to 49 Cents for the Fourth Quarter 2010; Results Include 5 Cents Per Diluted Share of Acquisition and Restructuring Related Costs
More informationLHC GROUP AND ALMOST FAMILY ANNOUNCE MERGER OF EQUALS TO CREATE LEADING NATIONAL PROVIDER OF IN-HOME HEALTHCARE SERVICES
LHC GROUP AND ALMOST FAMILY ANNOUNCE MERGER OF EQUALS TO CREATE LEADING NATIONAL PROVIDER OF IN-HOME HEALTHCARE SERVICES National platform enables greater service and continuity across continuum of care
More informationSYNNEX Concentrix Division Announces the Acquisition of Convergys
Filed by SYNNEX Corporation pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company:
More informationZimmer Biomet Reports Second Quarter 2016 Financial Results
July 28, 2016 Zimmer Biomet Reports Second Quarter 2016 Financial Results -- Net Sales of $1.934 billion represent an increase of 65.6% over the prior year period, and an increase of 4.5% on an adjusted
More informationMcKesson Corporation Q2 Fiscal 2019 Financial Performance. Financial Results and Company Highlights October 25, 2018
McKesson Corporation Q2 Fiscal 2019 Financial Performance Financial Results and Company Highlights October 25, 2018 Forward-Looking Statements Some of the information in this presentation is not historical
More informationInvestor Presentation. December 2018
Investor Presentation December 2018 Disclaimer This Presentation has been prepared and issued by Nomad Foods Limited (the "Company"). This Presentation has been provided solely for information and background.
More informationIFF Q Earnings Conference Call
INTERNATIONAL FLAVORS & FRAGRANCES IFF Q2 2018 Earnings Conference Call August 8, 2018 Cautionary Statement This presentation contains forward-looking statements within the meaning of Section 27A of the
More informationLHC Group and Almost Family: A Leading National Provider of In-Home Healthcare. November 16, 2017
LHC Group and Almost Family: A Leading National Provider of In-Home Healthcare November 16, 2017 Forward-Looking Statements This presentation contains forward looking statements (as defined in the Securities
More informationWaters Corporation Management Presentation. July 2018
Waters Corporation Management Presentation July 2018 Cautionary Statements This presentation may contain forward-looking statements regarding future results and events. For this purpose, any statements
More informationjuly 2012 CEB to Acquire SHL Compelling Value Creation, Growth, and Scale Opportunity
july 2012 CEB to Acquire SHL Compelling Value Creation, Growth, and Scale Opportunity Safe Harbor Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities
More informationHelping Clients Win with Digital
First Quarter 2018 Earnings Supplement Helping Clients Win with Digital May 7, 2018 2017 Cognizant Forward Looking Statements and Non-GAAP Financial Measures This earnings supplement includes statements
More informationHelping people look and feel their best
Alliance Boots Helping people look and feel their best 2007/08 Annual Review for the period ended 31 March 2008 Our mission Our mission is to become the world s leading pharmacyled health and beauty group.
More informationROTH Capital Partners 30 th Annual Conference. Monday, March 12, 2018
Monday, March 12, 2018 1 Forward-Looking Statements This presentation may contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements
More informationDiplomat s Acquisition of LDI Integrated Pharmacy Services. Nov. 15, 2017
Diplomat s Acquisition of LDI Integrated Pharmacy Services Nov. 15, 2017 1 DISCLAIMERS NON-GAAP INFORMATION We define Adjusted EBITDA as net income (loss) before interest expense, income taxes, depreciation
More informationImportant Information for Investors and Stockholders
March 1, 2010 Important Information for Investors and Stockholders This presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any
More informationCAGNY Conference. February 22, 2018
CAGNY Conference February 22, 2018 Disclaimer This presentation has been prepared and issued by Nomad Foods Limited (the "Company"). This Presentation has been provided solely for information and background.
More informationANALYST AND INVESTOR MEETINGS. September 2018
ANALYST AND INVESTOR MEETINGS September 2018 FY18 OVERVIEW FY18 FINANCIAL HIGHLIGHTS NET REVENUE ADJUSTED ADJUSTED ECOMMERCE $9.4bn OPERATING OPERATING as % of NET INCOME MARGIN REVENUE ORGANIC GROWTH
More informationSecond Quarter 2017 Financial Results
Technology Insight Innovation Second Quarter 2017 Financial Results August 9 th, 2017 Technology Insight Innovation Disclaimer Forward Looking Statements Certain statements included in this presentation
More informationInvestor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
More informationUBS Healthcare Conference John J. Greisch, President and CEO. May 22, 2017
UBS Healthcare Conference John J. Greisch, President and CEO May 22, 2017 Forward Looking Statements This presentation contains forward-looking statements, within the meaning of the Private Securities
More informationSCOTIABANK BACK TO SCHOOL CONFERENCE. September 15, 2015
SCOTIABANK BACK TO SCHOOL CONFERENCE September 15, 2015 DISCLAIMER STATEMENT Forward Looking Information This presentation contains information about Hudson s Bay Company including its direct and indirect
More informationCreating a GLOBAL PACKAGING LEADER
Creating a GLOBAL PACKAGING LEADER January 26, 2015 Page 1 Forward Looking Statements Forward-Looking Statements This document contains forward-looking statements within the meaning of the Private Securities
More informationRent-A-Center today is
INVESTOR PRESENTATION FIRST QUARTER 2014 Safe Harbor This presentation contains forward-looking statements that involve risks and uncertainties. Such forward-looking statements generally can be identified
More informationHorizon Global First Quarter 2016 Earnings Presentation
Horizon Global First Quarter 2016 Earnings Presentation May 3, 2016 1 Safe Harbor Statement Forward-Looking Statements This presentation may contain "forward-looking statements" as defined in the Private
More informationWolters Kluwer 2016 Full-Year Results
Wolters Kluwer 2016 Full-Year Results Nancy McKinstry CEO Kevin Entricken CFO February 22, 2017 2016 Full-Year Results 1 Forward-looking Statements This presentation contains forward-looking statements.
More informationWaters Corporation Management Presentation
Waters Corporation Management Presentation Chris O Connell Chairman & Chief Executive Officer January 2019 Cautionary Statements This presentation may contain forward-looking statements regarding future
More informationPowering healthcare provider success
Powering healthcare provider success Now and in the future Investor Information September 2018 TRANSFORMING HEALTHCARE TOGETHER Premier Inc. 2018 1 Forward-looking statements and non-gaap financial measures
More informationA Winning Combination: Creating a Consumer Goods Powerhouse
A Winning Combination: Creating a Consumer Goods Powerhouse December 14, 2015 Forward-Looking Statements Statements in this presentation that are not historical in nature constitute forward looking statements.
More informationInvestor Presentation. February 2018
Investor Presentation February 2018 1 Forward Looking Statements Important Information About Littelfuse, Inc. This presentation does not constitute or form part of, and should not be construed as, an offer
More informationVeritiv Corporation Fourth Quarter and Fiscal Year 2017 Financial Results March 1, 2018
Veritiv Corporation Fourth Quarter and Fiscal Year 2017 Financial Results March 1, 2018 Tom Morabito Director of Investor Relations 2 Safe Harbor Provision Certain statements contained in this presentation
More informationSimplification and growth
Simplification and growth Alex Wynaendts New York, December 6, 2018 CEO Helping people achieve a lifetime of financial security Clear progress towards achieving attractive financial results 2 Normalized
More informationZebra Technologies Second-Quarter 2018 Results. August 7, 2018
Zebra Technologies Second-Quarter 2018 Results August 7, 2018 Safe Harbor Statement Statements made in this presentation which are not statements of historical fact are forward-looking statements and are
More informationZimmer Biomet Reports Second Quarter 2017 Financial Results
Zimmer Biomet Reports Second Quarter 2017 Financial Results Jul 27, 2017 - Net sales of $1.954 billion for the second quarter represent an increase of 1.1% over the prior year period, and an increase of
More information5 Q & A. Agenda. Introduction Ben Robinson Strategy Director. Strategy and Business update Guy Dubois CEO. Financial update David Arnott CFO
Financial Results & Business Update Quarter and year ended 1 December 2011 Disclaimer NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO OR FROM THE UNITED STATES OR ANY OTHER
More informationJarden Investor Presentation. October 14, 2015
Jarden Investor Presentation October 14, 2015 Cautionary Statement Please note that in this presentation, we may discuss events or results that have not yet occurred or been realized, commonly referred
More informationSTRATEGIC PARTNERSHIP WITH ALTRIA TO ACCELERATE GROWTH AND INNOVATION
NASDAQ / TSX TICKER CRON STRATEGIC PARTNERSHIP WITH ALTRIA TO ACCELERATE GROWTH AND INNOVATION December 2018 Disclaimers & Cautionary Statements C R O N O S G R O U P INC. This communication contains forward-looking
More informationJohnson Controls reports solid fourth quarter and full year earnings and provides fiscal 2018 guidance
FOR IMMEDIATE RELEASE CONTACT: Investors: Antonella Franzen (609) 720-4665 Ryan Edelman (609) 720-4545 Media: Fraser Engerman (414) 524-2733 Johnson Controls reports solid fourth quarter and full year
More informationLyondellBasell Acquisition of A. Schulman
LyondellBasell Acquisition of A. Schulman Creating an Advanced Polymer Solutions Leader February 15, 2018 1 Cautionary Note Regarding Forward-looking Statements The statements in this communication relating
More informationInvestor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
More information2006 Interim Results. 9 August 2006
2006 Interim Results 9 August 2006 Agenda Introduction Financial review Review of the business Richard Harvey Group Chief Executive Andrew Moss Group Finance Director Richard Harvey Review of AmerUs Tom
More informationAccelerating our IPT strategy
Accelerating our IPT strategy GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture Transaction lays foundation for separation of GSK to create two new UK-based
More informationMAISONS DU MONDE: FULL-YEAR 2017 RESULTS
PRESS RELEASE MAISONS DU MONDE: FULL-YEAR 2017 RESULTS Very good performance across the board, in line with targets Solid sales growth and profitability Excellent free cash flow generation and strong deleveraging
More informationWALGREENS BOOTS ALLIANCE, INC.
WALGREENS BOOTS ALLIANCE, INC. FORM 424B5 (Prospectus filed pursuant to Rule 424(b)(5)) Filed 11/12/14 Address 108 WILMOT ROAD DEERFIELD, IL 60015 Telephone (847) 315-2500 CIK 0001618921 SIC Code 5912
More informationFourth Quarter 2018 Earnings Conference Call
Fourth Quarter 2018 Earnings Conference Call Larry Merlo President & Chief Executive Officer Eva Boratto Executive Vice President & Chief Financial Officer February 20, 2019 Cautionary Statement Regarding
More informationHorizon Global Third Quarter 2017 Earnings Presentation
Horizon Global Third Quarter 2017 Earnings Presentation October 31, 2017 Q1 2016 Earnings 1 Safe Harbor Statement Forward-Looking Statements This presentation may contain "forward-looking statements" as
More informationConsolidated Financial Statements
Alliance Boots GmbH Consolidated Financial Statements for the period ended 31 March 2008 Alliance Boots GmbH 2007/08 Consolidated Financial Statements Contents Independent auditor s report 1 Group income
More informationdbaccess Global Consumer Conference June 12, 2018
dbaccess Global Consumer Conference June 12, 2018 Disclaimer This Presentation has been prepared and issued by Nomad Foods Limited (the "Company"). This Presentation has been provided solely for information
More informationMcKESSON REPORTS FISCAL 2015 THIRD-QUARTER RESULTS
McKESSON REPORTS FISCAL 2015 THIRD-QUARTER RESULTS Revenues of $47 billion for the third quarter, up 37%. Third-quarter GAAP earnings per diluted share from continuing operations of $2.01, up 187%. Third-quarter
More information